National Vaccination Day, on March 16 in India, marks the 1995 Pulse Polio Immunisation launch, raising awareness about ...

Merck & Co Inc (NYSE:MRK) announced the presentation of results from two Phase 3 trials of doravirine/islatravir (DOR/ISL) in ...

Some vaccines have trace levels of thimerosal left over from the manufacturing process (less than 1 µg thimerosal per 0.5 mL dose of vaccine), [25] an amount that is considered insignificant.

Early administration of high-titre COVID-19 convalescent plasma prevents hospitalisation and death in immunocompromised ...

Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir ...

Also Read: Merck Injects $1 Billion To Expand Vaccine Production In US Merck plans ... results for the primary endpoint (HIV-1 RNA ≥50 copies/mL) showed that 1.5% of participants who switched ...

Catani and colleagues provide data on antigenic properties of neuraminidase proteins of pandemic H1N1 and show that antigenic diversity of the neuraminidase from 2009 to 2020 largely falls into two ...

Gilead has reported results for a once-yearly intramuscular injection that show blood concentrations of lenacapavir exceeded ...

MAGA influencer and former White House adviser Steve Bannon lashed out at President Donald Trump's White House after the ...